This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

William K. Sherwin, MD, PhD; Herbert Goldschmidt, MD
Department of Dermatology University of Pennsylvania Medical School Philadelphia, PA 19104

Arch Dermatol. 1987;123(10):1269.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

We would like to comment on the editorial by Dr June K. Robinson¹ concerning adequate treatment and follow-up care for nonmelanoma cutaneous cancer. Specifically, we disagree with the statements that (1) "all primary tumors of the medial canthus be resected by Mohs micrographic surgery" and (2) that in surgical treatment of basal cell carcinomas involving "the eyelids, canthi, pinnae, nasolabial folds, and alae nasi, it is not recommended that a 4-mm margin be utilized, but, rather, that the precise and careful control afforded by Mohs micrographic surgery should be utilized."

While we do not dispute the value of Mohs microscopically controlled surgery, especially for the treatment of extensive or otherwise difficult skin cancers, the use of a single technique to the exclusion of all others will not always result in the optimum outcome for an individual patient. Like many of our colleagues, we have treated thousands . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?